Humoral immunity developed by DNA vaccine INO-4800 is effective against SARS-CoV-2 variants
A team of international scientists recently demonstrated that antibodies generated in response to the DNA vaccine INO-4800 can effectively neutralize …
Home ยป
Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers
CoronaVac is a well-tolerated vaccine containing inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it induced humoral responses in …
Sinovac COVID-19 vaccine shows 50% effectiveness in a cohort of Brazilian healthcare workers
CoronaVac is a well-tolerated vaccine containing inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and it induced humoral responses in …
Can limiting the priming dose of a SARS-CoV-2 vaccine improve immunity?
Several vaccines have been developed, approved and rolled out to prevent coronavirus disease 2019 (COVID-19), caused by severe acute respiratory …
The use of mammalian cell surface display for rapid characterization of SARS-CoV-2 variants
A research group from the U.S. demonstrated the practicality of a spike display system in order to accelerate vaccine design, …
Researchers offer large-scale screening of potential broad-spectrum SARS-CoV-2 antivirals
The search for effective and safe antivirals against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen responsible for the …
Combined clinical and genomic data better predicts COVID-19 severity
The current COVID-19 outbreak is one of the worst pandemics in history and has claimed millions of lives across the …
Emergence of novel SARS-CoV-2 variants and co-mutations in India
A new study has uncovered genetic changes in a group of similar severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants …
New Colombian SARS-CoV-2 lineage shares antibody-resistant mutations with other variants
Scientists in Colombia have identified a new highly divergent SARS-CoV-2 lineage with Spike substitutions L249S and E484K. These same mutations …
Salivary IgG to SARS-CoV-2 after mild COVID-19
A team of researchers based in Stockholm, Sweden, has demonstrated that individuals exposed to severe acute respiratory syndrome coronavirus 2 …
Whole genome sequencing may guide blood cancer treatment
For certain blood cancers, such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), deciding whether patients need an aggressive …
Novel bioinformatics tool could help improve COVID-19 diagnosis
Improved diagnostics are important in containing the ongoing coronavirus disease 2019 (COVID-19) pandemic as well as understanding the biology of …
SARS-CoV-2 escapes host immune responses by modulating dendritic cell maturation
A team of scientists from Italy and the USA has recently explored the maturation pattern of conventional dendritic cells (cDCs) …
Pfizer SARS-CoV-2 vaccine effective from day 11 post 1st vaccination
New research from a team of scientists in Australia suggests that the second ‘booster’ dose of the Pfizer-BioNTech vaccine may …
China's SARS and SARS-CoV-2 outbreak management in comparative perspective
Since the onset of the coronavirus disease 2019 (COVID-19) pandemic – caused by the severe acute respiratory syndrome coronavirus 2 …
Humidity created inside facemasks may help combat COVID-19, study finds
In the fight against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), one of …
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein …
New SARS-CoV-2 variant found in newborn child with seizures in the United States
Researchers at a hospital in Washington D.C. found a new mutant strain of the virus in a neonatal patient with …